C/EBPE--STUDY OF A NOVEL MYELOID TRANSCRIPTION FACTOR
C/EBPE--新型骨髓转录因子的研究
基本信息
- 批准号:2882295
- 负责人:
- 金额:$ 34.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1979
- 资助国家:美国
- 起止时间:1979-07-01 至 2003-02-28
- 项目状态:已结题
- 来源:
- 关键词:DNA footprinting antisense nucleic acid cell differentiation complementary DNA enhancer binding protein gene expression gene targeting genetic promoter element genetic regulation genetic transcription genetically modified animals human tissue intermolecular interaction laboratory mouse messenger RNA myeloid stem cell polymerase chain reaction protein structure function retinoids tissue /cell culture transcription factor transfection /expression vector yeast two hybrid system
项目摘要
We have recently cloned a novel human gene (C/EBPepsilon) which is a
member of large family of transcriptional factors known as the CCAAT
enhancer-binding proteins (C/EBP). C/EBPepsilon is uniquely expressed
in granulocytic precursor cells, and this expression is markedly
enhanced by retinoids. C/EBP protein exhibits strong and specific
binding to double-stranded DNA containing consensus C/EBP sites.
Cotransfection of either the sense or anti-sense C/EBPepsilon expression
constructs together with CAT-reporter vectors containing myeloid-
specific c-mim or human myeloperoxidase promoters suggest a role for
C/EBPepsilon in the regulation of a subset of myeloid-specific genes.
Likewise, over- and under-expression of C/EBPepsilon in a myeloid line
(NB4) increased and decreased the clonal growth of the cells,
respectively. Specific Aim 1 will study the modulation of expression
of C/EBPepsilon in myeloid cells including: A.) Which myeloid cells
express C/EBPepsilon; B.) What is the mechanism by which retinoids
induce expression of C/EBPepsilon; C.) How is expression of C/EBPepsilon
regulated. In Specific Aim 2, we will determine partners of C/EBPepsilon
and how these partners influence the biology of C/EBPepsilon. Using the
yeast two hybrid selection system, we have identified CREB2 as one of
the frequent partners of C/EBPepsilon. Binding of CREB2 to C/EBPepsilon
will be confirmed by several additional in vitro and in vivo techniques
and its influence on C/EBPepsilon function will be explored. Other
partners of C/EBPepsilon will also be identified and studied. Specific
Aim 3 will elucidate biological function of C/EBPepsilon in vitro and
in mice. Using both transient and stable sense (S)-and antisense (AS)-
expression vectors and oliogonucleotides of C/EBPepsilon, the role that
C/EBPepsilon plays in the combinatorial process of myeloid
differentiation will be explored using human myeloid cell lines and the
murine 32D myeloid cells. In vivo experiments will include: 1.) Study
of CMV-driven C/EBPepsilon S- and AS-expressing transgenic mice. 2.)
Analysis of C/EBPepsilon germline knock-out mice and C/EBPepsilon
deletional chimeras. Specific Aim 4 will dissect the transcriptional
activity of the C/EBPepsilon molecule and identify its target genes.
The first set of experiments, will define regions of transcriptional
activation and repression of the C/EBPepsilon molecule. In further
experiments, we will define the consensus binding sequences of
C/EBPepsilon using CASTing and whole genome PCR in order to begin to
identify novel C/EBPepsilon target sequences and genes. In addition,
we will study in detail the ability of C/EBPepsilon to transactivate the
myeloperoxidase and neutrophil elastase genes. Taken together, these
studies will provide an understanding of C/EBPepsilon, a retinoid
inducible, myeloid specific transcriptional activator.
我们最近克隆了一个新的人类基因(C/EB肽),
称为CCAAT的转录因子大家族成员
增强子结合蛋白(C/EBP)。 C/EB肽是唯一表达的
在粒细胞前体细胞中,这种表达明显
被类维生素A强化 C/EBP蛋白具有较强的特异性,
与含有共有C/EBP位点的双链DNA结合。
正义或反义C/EB肽表达的共转染
构建体以及含有髓样-
特异性c-mim或人髓过氧化物酶启动子提示了
C/EB肽在一组骨髓特异性基因调控中的作用
同样,在骨髓细胞系中C/EB肽的过度表达和表达不足,
(NB4)增加和减少细胞的克隆生长,
分别 具体目标1将研究表达的调节
C/EB肽在骨髓细胞中的表达,包括:A.)哪些骨髓细胞
表达C/EB肽; B.)类维生素A的作用机制是什么
诱导C/EB肽表达; C.)如何表达C/EB肽
监管.在具体目标2中,我们将确定C/EB Peptide的合作伙伴
以及这些伙伴如何影响C/EB肽的生物学。 使用
酵母双杂交选择系统,我们已经确定CREB 2作为一个
C/EBPeptide的合作伙伴。 CREB 2与C/EB肽的结合
将通过几种额外的体外和体内技术进行证实
并探讨其对C/EB肽功能的影响。 其他
还将鉴定和研究C/EB肽的伙伴。 具体
目的3阐明C/EB肽的体外生物学功能,
对小鼠 使用瞬时和稳定的正义(S)和反义(AS)-
C/EB肽的表达载体和寡聚核苷酸,
C/EB肽在髓系细胞组合过程中的作用
将使用人髓样细胞系探索分化,
小鼠32 D骨髓细胞。 体内实验将包括:1.)研究
CMV驱动的C/EB肽S-和AS-表达转基因小鼠。 2.)的情况。
C/EBPepsilon种系基因敲除小鼠和C/EBPepsilon的分析
缺失嵌合体具体目标4将剖析转录
C/EB肽分子的活性并鉴定其靶基因。
第一组实验,将定义转录区域,
C/EB肽分子的激活和抑制。 进一步
实验中,我们将定义的共识结合序列
C/EBPeptide使用CAST和全基因组PCR,以便开始
鉴定新C/EB肽靶序列和基因。 此外,本发明还提供了一种方法,
我们将详细研究C/EB肽反式激活
髓过氧化物酶和中性粒细胞弹性蛋白酶基因。综上所述各项
研究将提供对C/EB肽的理解,
可诱导骨髓特异性转录激活因子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harold Phillip Koeffler其他文献
Harold Phillip Koeffler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Harold Phillip Koeffler', 18)}}的其他基金
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches
将脂肪肉瘤的基因组改变与药物反应联系起来并确定新的治疗方法
- 批准号:
9919544 - 财政年份:2016
- 资助金额:
$ 34.83万 - 项目类别:
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches
将脂肪肉瘤的基因组改变与药物反应联系起来并确定新的治疗方法
- 批准号:
9173247 - 财政年份:2016
- 资助金额:
$ 34.83万 - 项目类别:
Pax5:Hematopoietic Transcription Factor Involved in ALL
Pax5:参与 ALL 的造血转录因子
- 批准号:
8449531 - 财政年份:2009
- 资助金额:
$ 34.83万 - 项目类别:
Pax5:Hematopoietic Transcription Factor Involved in ALL
Pax5:参与 ALL 的造血转录因子
- 批准号:
7860682 - 财政年份:2009
- 资助金额:
$ 34.83万 - 项目类别:
Pax5:Hematopoietic Transcription Factor Involved in ALL
Pax5:参与 ALL 的造血转录因子
- 批准号:
7735955 - 财政年份:2009
- 资助金额:
$ 34.83万 - 项目类别:
Pax5:Hematopoietic Transcription Factor Involved in ALL
Pax5:参与 ALL 的造血转录因子
- 批准号:
8256532 - 财政年份:2009
- 资助金额:
$ 34.83万 - 项目类别:
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
查尔斯德鲁大学/加州大学洛杉矶分校癌症中心合作消除癌症健康
- 批准号:
7943032 - 财政年份:2009
- 资助金额:
$ 34.83万 - 项目类别:
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
查尔斯德鲁大学/加州大学洛杉矶分校癌症中心合作消除癌症健康
- 批准号:
7789951 - 财政年份:2009
- 资助金额:
$ 34.83万 - 项目类别:
相似海外基金
Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
- 批准号:
22K09003 - 财政年份:2022
- 资助金额:
$ 34.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
- 批准号:
21K07762 - 财政年份:2021
- 资助金额:
$ 34.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
- 批准号:
20K16927 - 财政年份:2020
- 资助金额:
$ 34.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
- 批准号:
20H00526 - 财政年份:2020
- 资助金额:
$ 34.83万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
- 批准号:
20K21245 - 财政年份:2020
- 资助金额:
$ 34.83万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
- 批准号:
G0900887/1 - 财政年份:2011
- 资助金额:
$ 34.83万 - 项目类别:
Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
- 批准号:
05558090 - 财政年份:1993
- 资助金额:
$ 34.83万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
- 批准号:
04453031 - 财政年份:1992
- 资助金额:
$ 34.83万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)